Encompass Health Corporation carries a market capitalization of 10.07B, placing it among publicly traded companies globally. Its enterprise value stands at 13.21B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 10.07B |
| Enterprise Value | 13.21B |
Encompass Health Corporation currently has 99.42M shares outstanding.
| Shares Outstanding | 99.42M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Encompass Health Corporation trades at a trailing price-to-earnings ratio of 15.90. The price-to-sales ratio is 1.60, and the price-to-book ratio stands at 6.61.
| PE Ratio | 15.90 |
| PS Ratio | 1.60 |
| PB Ratio | 6.61 |
| P/TBV Ratio | 5.54 |
| P/FCF Ratio | 5.09 |
| P/OCF Ratio | 8.07 |
On an enterprise value basis, Encompass Health Corporation trades at an EV/EBITDA multiple of 9.28 and an EV/FCF ratio of 6.50. The EV/Sales ratio of 2.18 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 12.14 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.18 |
| EV / EBITDA | 9.28 |
| EV / EBIT | 12.14 |
| EV / FCF | 6.50 |
Encompass Health Corporation maintains a current ratio of 1.17, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 82.84, indicating elevated leverage, while an interest coverage ratio of 11.56 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.17 |
| Quick Ratio | 0.90 |
| Debt / Equity | 82.84 |
| Debt / EBITDA | 1.96 |
| Interest Coverage | 11.56 |
Encompass Health Corporation posts a return on equity of 50.81 and a return on invested capital of 14.62.
| Return on Equity (ROE) | 50.81 |
| Return on Assets (ROA) | 8.73 |
| Return on Invested Capital (ROIC) | 14.62 |
| Return on Capital Employed (ROCE) | 10.62 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Encompass Health Corporation has paid 207.70M in income taxes, reflecting an effective tax rate of 20.71.
| Income Tax | 207.70M |
| Effective Tax Rate | 20.71 |
Encompass Health Corporation's stock has declined approximately -16.42663% over the past 52 weeks. The 50-day moving average sits at 103.72, while the 200-day moving average is 110.77.
| Beta (5Y) | N/A |
| 52-Week Price Change | -16.42663% |
| 50-Day Moving Average | 103.72 |
| 200-Day Moving Average | 110.77 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Encompass Health Corporation generated 6.07B in revenue and converted that into 609.20M in net income, yielding earnings per share of 7.81. EBITDA reached 1.42B, while operating income came in at 1.09B.
| Revenue | 6.07B |
| Gross Profit | 5.04B |
| Operating Income | 1.09B |
| Pretax Income | 1.00B |
| Net Income | 609.20M |
| EBITDA | 1.42B |
| EBIT | 1.09B |
| Earnings Per Share (EPS) | 7.81 |
Encompass Health Corporation holds 110.50M in cash and equivalents against 2.79B in total debt, resulting in a net debt position of 2.46B. Total book value stands at 1.47B, with working capital of 152.30M providing operational flexibility.
| Cash & Cash Equivalents | 110.50M |
| Total Debt | 2.79B |
| Net Debt | 2.46B |
| Equity (Book Value) | 1.47B |
| Book Value Per Share | 14.64 |
| Working Capital | 152.30M |
Encompass Health Corporation produced 1.20B in operating cash flow over the past twelve months. After subtracting -735.70M in capital expenditures, free cash flow totaled 464.40M - equivalent to 4.64 per share.
| Operating Cash Flow | 1.20B |
| Capital Expenditures | -735.70M |
| Free Cash Flow | 464.40M |
| FCF Per Share | 4.64 |
Encompass Health Corporation operates with a gross margin of 83.12, reflecting its pricing power and cost economics. The operating margin of 17.93 and net profit margin of 10.04 provide insight into operational efficiency.
| Gross Margin | 83.12 |
| Operating Margin | 17.93 |
| Pretax Margin | 16.54 |
| Profit Margin | 10.04 |
| EBITDA Margin | 23.47 |
The company's payout ratio of 7.36 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.73 |
| Dividend Yield | N/A |
| Payout Ratio | 7.36 |
| Shareholder Yield | 4.16 |
| FCF Yield | 19.66 |
Encompass Health Corporation's most recent stock split took place on July 1, 2022 with a 1000:1257 split ratio.
| Last Split Date | 7/1/2022 |
| Split Ratio | 1000:1257 |
Encompass Health Corporation posts an Altman Z-Score of 3.56, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.56 |